Skip to main content
Erschienen in: Diabetologia 10/2006

01.10.2006 | Article

Insulin modulates the secretion of proteins from mature 3T3-L1 adipocytes: a role for transcriptional regulation of processing

verfasst von: P. Wang, J. Keijer, A. Bunschoten, F. Bouwman, J. Renes, E. Mariman

Erschienen in: Diabetologia | Ausgabe 10/2006

Einloggen, um Zugang zu erhalten

Abstract

Aims/hypothesis

Under conditions of insulin resistance and type 2 diabetes, fat cells are subjected to increased levels of insulin, which may have a major impact on the secretion of adipokines.

Materials and methods

Using transcriptomics and proteomics, we investigated how insulin affects the transcription and protein secretion profile of mature 3T3-L1 adipocytes.

Results

We found that insulin has a significant impact on protein secretion of 3T3-L1 adipocytes. However, transcription is not the major regulation point for these secreted proteins. For extracellular matrix components, our data suggest that the mRNA level of processing enzymes, but not of target proteins, is the regulating point at which insulin stimulates secretion and function of the relevant proteins. Among these enzymes, we report a novel finding, namely that sulfatase 2 gene is regulated by insulin, which may induce a functional change in cultured adipocytes.

Conclusions/interpretation

We propose that enhancement of protein processing and secretion rather than transcription of the secreted protein genes is part of the strategic role of insulin in the induction of cellular responses.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
2.
Zurück zum Zitat Fasshauer M, Paschke R (2003) Regulation of adipocytokines and insulin resistance. Diabetologia 46:1594–1603PubMedCrossRef Fasshauer M, Paschke R (2003) Regulation of adipocytokines and insulin resistance. Diabetologia 46:1594–1603PubMedCrossRef
3.
Zurück zum Zitat Lafontan M (2005) Fat cells: afferent and efferent messages define new approaches to treat obesity. Annu Rev Pharmacol Toxicol 45:119–146PubMedCrossRef Lafontan M (2005) Fat cells: afferent and efferent messages define new approaches to treat obesity. Annu Rev Pharmacol Toxicol 45:119–146PubMedCrossRef
4.
Zurück zum Zitat Faraj M, Lu HL, Cianflone K (2004) Diabetes, lipids, and adipocyte secretagogues. Biochem Cell Biol 82:170–190PubMedCrossRef Faraj M, Lu HL, Cianflone K (2004) Diabetes, lipids, and adipocyte secretagogues. Biochem Cell Biol 82:170–190PubMedCrossRef
5.
Zurück zum Zitat Summers SA, Whiteman EL, Birnbaum MJ (2000) Insulin signaling in the adipocyte. Int J Obes Relat Metab Disord 24(Suppl 4):S67–S70PubMed Summers SA, Whiteman EL, Birnbaum MJ (2000) Insulin signaling in the adipocyte. Int J Obes Relat Metab Disord 24(Suppl 4):S67–S70PubMed
6.
Zurück zum Zitat Lin Y, Berg AH, Iyengar P et al (2005) The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J Biol Chem 280:4617–4626PubMedCrossRef Lin Y, Berg AH, Iyengar P et al (2005) The hyperglycemia-induced inflammatory response in adipocytes: the role of reactive oxygen species. J Biol Chem 280:4617–4626PubMedCrossRef
7.
Zurück zum Zitat Bogan JS, Lodish HF (1999) Two compartments for insulin-stimulated exocytosis in 3T3-L1 adipocytes defined by endogenous ACRP30 and GLUT4. J Cell Biol 146:609–620PubMedCrossRef Bogan JS, Lodish HF (1999) Two compartments for insulin-stimulated exocytosis in 3T3-L1 adipocytes defined by endogenous ACRP30 and GLUT4. J Cell Biol 146:609–620PubMedCrossRef
8.
Zurück zum Zitat Millar CA, Meerloo T, Martin S et al (2000) Adipsin and the glucose transporter GLUT4 traffic to the cell surface via independent pathways in adipocytes. Traffic 1:141–151PubMedCrossRef Millar CA, Meerloo T, Martin S et al (2000) Adipsin and the glucose transporter GLUT4 traffic to the cell surface via independent pathways in adipocytes. Traffic 1:141–151PubMedCrossRef
9.
Zurück zum Zitat Chen X, Cushman SW, Pannell LK, Hess S (2005) Quantitative proteomic analysis of the secretory proteins from rat adipose cells using a 2D liquid chromatography-MS/MS approach. J Proteome Res 4:570–577PubMedCrossRef Chen X, Cushman SW, Pannell LK, Hess S (2005) Quantitative proteomic analysis of the secretory proteins from rat adipose cells using a 2D liquid chromatography-MS/MS approach. J Proteome Res 4:570–577PubMedCrossRef
10.
Zurück zum Zitat Wang P, Mariman E, Keijer J et al (2004) Profiling of the secreted proteins during 3T3-L1 adipocyte differentiation leads to the identification of novel adipokines. Cell Mol Life Sci 61:2405–2417PubMedCrossRef Wang P, Mariman E, Keijer J et al (2004) Profiling of the secreted proteins during 3T3-L1 adipocyte differentiation leads to the identification of novel adipokines. Cell Mol Life Sci 61:2405–2417PubMedCrossRef
11.
Zurück zum Zitat Pellis L, Franssen-van Hal NL, Burema J, Keijer J (2003) The intraclass correlation coefficient applied for evaluation of data correction, labeling methods, and rectal biopsy sampling in DNA microarray experiments. Physiol Genomics 16:99–106PubMedCrossRef Pellis L, Franssen-van Hal NL, Burema J, Keijer J (2003) The intraclass correlation coefficient applied for evaluation of data correction, labeling methods, and rectal biopsy sampling in DNA microarray experiments. Physiol Genomics 16:99–106PubMedCrossRef
12.
Zurück zum Zitat Van Der Meer-Van Kraaij C, Van Lieshout EM, Kramer E, Van Der Meer R, Keijer J (2003) Mucosal pentraxin (Mptx), a novel rat gene 10-fold down-regulated in colon by dietary heme. FASEB J 17:1277–1285CrossRef Van Der Meer-Van Kraaij C, Van Lieshout EM, Kramer E, Van Der Meer R, Keijer J (2003) Mucosal pentraxin (Mptx), a novel rat gene 10-fold down-regulated in colon by dietary heme. FASEB J 17:1277–1285CrossRef
13.
Zurück zum Zitat Bouwman F, Renes J, Mariman E (2004) A combination of protein profiling and isotopomer analysis using matrix-assisted laser desorption/ionization-time of flight mass spectrometry reveals an active metabolism of the extracellular matrix of 3T3-L1 adipocytes. Proteomics 4:3855–3863PubMedCrossRef Bouwman F, Renes J, Mariman E (2004) A combination of protein profiling and isotopomer analysis using matrix-assisted laser desorption/ionization-time of flight mass spectrometry reveals an active metabolism of the extracellular matrix of 3T3-L1 adipocytes. Proteomics 4:3855–3863PubMedCrossRef
14.
Zurück zum Zitat Ueki K, Fruman DA, Yballe CM et al (2003) Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling. J Biol Chem 278:48453–48466PubMedCrossRef Ueki K, Fruman DA, Yballe CM et al (2003) Positive and negative roles of p85 alpha and p85 beta regulatory subunits of phosphoinositide 3-kinase in insulin signaling. J Biol Chem 278:48453–48466PubMedCrossRef
15.
Zurück zum Zitat Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P (2002) Cell junctions, cell adhesion, and the extracellular matrix. In: Gibbs S (ed) Molecular biology of the cell. Garland, New York, pp 1065–1126 Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P (2002) Cell junctions, cell adhesion, and the extracellular matrix. In: Gibbs S (ed) Molecular biology of the cell. Garland, New York, pp 1065–1126
16.
Zurück zum Zitat Kivirikko KI, Helaakoski T, Tasanen K et al (1990) Molecular biology of prolyl 4-hydroxylase. Ann N Y Acad Sci 580:132–142PubMedCrossRef Kivirikko KI, Helaakoski T, Tasanen K et al (1990) Molecular biology of prolyl 4-hydroxylase. Ann N Y Acad Sci 580:132–142PubMedCrossRef
17.
Zurück zum Zitat Ricard-Blum S, Bernocco S, Font B et al (2002) Interaction properties of the procollagen C-proteinase enhancer protein shed light on the mechanism of stimulation of BMP-1. J Biol Chem 277:33864–33869PubMedCrossRef Ricard-Blum S, Bernocco S, Font B et al (2002) Interaction properties of the procollagen C-proteinase enhancer protein shed light on the mechanism of stimulation of BMP-1. J Biol Chem 277:33864–33869PubMedCrossRef
18.
Zurück zum Zitat Chen G, Gharib TG, Huang CC et al (2002) Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 1:304–313PubMedCrossRef Chen G, Gharib TG, Huang CC et al (2002) Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 1:304–313PubMedCrossRef
19.
Zurück zum Zitat Griffin TJ, Gygi SP, Ideker T et al (2002) Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol Cell Proteomics 1:323–333PubMedCrossRef Griffin TJ, Gygi SP, Ideker T et al (2002) Complementary profiling of gene expression at the transcriptome and proteome levels in Saccharomyces cerevisiae. Mol Cell Proteomics 1:323–333PubMedCrossRef
20.
Zurück zum Zitat Hegde PS, White IR, Debouck C (2003) Interplay of transcriptomics and proteomics. Curr Opin Biotechnol 14:647–651PubMedCrossRef Hegde PS, White IR, Debouck C (2003) Interplay of transcriptomics and proteomics. Curr Opin Biotechnol 14:647–651PubMedCrossRef
21.
Zurück zum Zitat Saltiel AR, Pessin JE (2002) Insulin signaling pathways in time and space. Trends Cell Biol 12:65–71PubMedCrossRef Saltiel AR, Pessin JE (2002) Insulin signaling pathways in time and space. Trends Cell Biol 12:65–71PubMedCrossRef
22.
Zurück zum Zitat Kido Y, Nakae J, Accili D (2001) Clinical review 125: the insulin receptor and its cellular targets. J Clin Endocrinol Metab 86:972–979PubMedCrossRef Kido Y, Nakae J, Accili D (2001) Clinical review 125: the insulin receptor and its cellular targets. J Clin Endocrinol Metab 86:972–979PubMedCrossRef
23.
Zurück zum Zitat Barthel A, Schmoll D, Unterman TG (2005) FoxO proteins in insulin action and metabolism. Trends Endocrinol Metab 16:183–189PubMedCrossRef Barthel A, Schmoll D, Unterman TG (2005) FoxO proteins in insulin action and metabolism. Trends Endocrinol Metab 16:183–189PubMedCrossRef
24.
Zurück zum Zitat Santini MT, Rainaldi G, Indovina PL (2000) Apoptosis, cell adhesion and the extracellular matrix in the three-dimensional growth of multicellular tumor spheroids. Crit Rev Oncol Hematol 36:75–87PubMed Santini MT, Rainaldi G, Indovina PL (2000) Apoptosis, cell adhesion and the extracellular matrix in the three-dimensional growth of multicellular tumor spheroids. Crit Rev Oncol Hematol 36:75–87PubMed
25.
Zurück zum Zitat Farrelly N, Lee YJ, Oliver J, Dive C, Streuli CH (1999) Extracellular matrix regulates apoptosis in mammary epithelium through a control on insulin signaling. J Cell Biol 144:1337–1348PubMedCrossRef Farrelly N, Lee YJ, Oliver J, Dive C, Streuli CH (1999) Extracellular matrix regulates apoptosis in mammary epithelium through a control on insulin signaling. J Cell Biol 144:1337–1348PubMedCrossRef
26.
Zurück zum Zitat Pierleoni C, Verdenelli F, Castellucci M, Cinti S (1998) Fibronectins and basal lamina molecules expression in human subcutaneous white adipose tissue. Eur J Histochem 42:183–188PubMed Pierleoni C, Verdenelli F, Castellucci M, Cinti S (1998) Fibronectins and basal lamina molecules expression in human subcutaneous white adipose tissue. Eur J Histochem 42:183–188PubMed
27.
Zurück zum Zitat Fossey SC, Mychaleckyj JC, Pendleton JK et al (2001) A high-resolution 6.0-megabase transcript map of the type 2 diabetes susceptibility region on human chromosome 20. Genomics 76:45–57PubMedCrossRef Fossey SC, Mychaleckyj JC, Pendleton JK et al (2001) A high-resolution 6.0-megabase transcript map of the type 2 diabetes susceptibility region on human chromosome 20. Genomics 76:45–57PubMedCrossRef
28.
Zurück zum Zitat Bernfield M, Gotte M, Park PW et al (1999) Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68:729–777PubMedCrossRef Bernfield M, Gotte M, Park PW et al (1999) Functions of cell surface heparan sulfate proteoglycans. Annu Rev Biochem 68:729–777PubMedCrossRef
29.
Zurück zum Zitat Iozzo RV (2001) Heparan sulfate proteoglycans: intricate molecules with intriguing functions. J Clin Invest 108:165–167PubMedCrossRef Iozzo RV (2001) Heparan sulfate proteoglycans: intricate molecules with intriguing functions. J Clin Invest 108:165–167PubMedCrossRef
30.
Zurück zum Zitat Wilsie LC, Chanchani S, Navaratna D, Orlando RA (2005) Cell surface heparan sulfate proteoglycans contribute to intracellular lipid accumulation in adipocytes. Lipids Health Dis 4:2PubMedCrossRef Wilsie LC, Chanchani S, Navaratna D, Orlando RA (2005) Cell surface heparan sulfate proteoglycans contribute to intracellular lipid accumulation in adipocytes. Lipids Health Dis 4:2PubMedCrossRef
31.
Zurück zum Zitat Mahley RW, Ji ZS (1999) Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res 40:1–16PubMed Mahley RW, Ji ZS (1999) Remnant lipoprotein metabolism: key pathways involving cell-surface heparan sulfate proteoglycans and apolipoprotein E. J Lipid Res 40:1–16PubMed
32.
Zurück zum Zitat Nakato H, Kimata K (2002) Heparan sulfate fine structure and specificity of proteoglycan functions. Biochim Biophys Acta 1573:312–318PubMed Nakato H, Kimata K (2002) Heparan sulfate fine structure and specificity of proteoglycan functions. Biochim Biophys Acta 1573:312–318PubMed
33.
Zurück zum Zitat Wang S, Ai X, Freeman SD et al (2004) QSulf1, a heparan sulfate 6-O-endosulfatase, inhibits fibroblast growth factor signaling in mesoderm induction and angiogenesis. Proc Natl Acad Sci USA 101:4833–4838PubMedCrossRef Wang S, Ai X, Freeman SD et al (2004) QSulf1, a heparan sulfate 6-O-endosulfatase, inhibits fibroblast growth factor signaling in mesoderm induction and angiogenesis. Proc Natl Acad Sci USA 101:4833–4838PubMedCrossRef
34.
Zurück zum Zitat Kozma EM, Olczyk K, Glowacki A et al (1996) Glycosaminoglycans of human serum and their alterations in diabetes mellitus. Acta Biochim Pol 43:567–574PubMed Kozma EM, Olczyk K, Glowacki A et al (1996) Glycosaminoglycans of human serum and their alterations in diabetes mellitus. Acta Biochim Pol 43:567–574PubMed
35.
Zurück zum Zitat Conde-Knape K (2001) Heparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complications. Diabetes Metab Res Rev 17:412–421PubMedCrossRef Conde-Knape K (2001) Heparan sulfate proteoglycans in experimental models of diabetes: a role for perlecan in diabetes complications. Diabetes Metab Res Rev 17:412–421PubMedCrossRef
36.
Zurück zum Zitat Kjellen L, Bielefeld D, Hook M (1983) Reduced sulfation of liver heparan sulfate in experimentally diabetic rats. Diabetes 32:337–342PubMedCrossRef Kjellen L, Bielefeld D, Hook M (1983) Reduced sulfation of liver heparan sulfate in experimentally diabetic rats. Diabetes 32:337–342PubMedCrossRef
37.
Zurück zum Zitat Kofoed-Enevoldsen A, Noonan D, Deckert T (1993) Diabetes mellitus induced inhibition of glucosaminyl N-deacetylase: effect of short-term blood glucose control in diabetic rats. Diabetologia 36:310–315PubMedCrossRef Kofoed-Enevoldsen A, Noonan D, Deckert T (1993) Diabetes mellitus induced inhibition of glucosaminyl N-deacetylase: effect of short-term blood glucose control in diabetic rats. Diabetologia 36:310–315PubMedCrossRef
38.
Zurück zum Zitat Parthasarathy N, Gotow LF, Bottoms JD et al (2000) Influence of glucose on production and N-sulfation of heparan sulfate in cultured adipocyte cells. Mol Cell Biochem 213:1–9PubMedCrossRef Parthasarathy N, Gotow LF, Bottoms JD et al (2000) Influence of glucose on production and N-sulfation of heparan sulfate in cultured adipocyte cells. Mol Cell Biochem 213:1–9PubMedCrossRef
39.
Zurück zum Zitat Olsson U, Egnell AC, Lee MR et al (2001) Changes in matrix proteoglycans induced by insulin and fatty acids in hepatic cells may contribute to dyslipidemia of insulin resistance. Diabetes 50:2126–2132PubMedCrossRef Olsson U, Egnell AC, Lee MR et al (2001) Changes in matrix proteoglycans induced by insulin and fatty acids in hepatic cells may contribute to dyslipidemia of insulin resistance. Diabetes 50:2126–2132PubMedCrossRef
40.
Zurück zum Zitat Ai X, Do AT, Lozynska O, Kusche-Gullberg M, Lindahl U, Emerson CP Jr (2003) QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling. J Cell Biol 162:341–351PubMedCrossRef Ai X, Do AT, Lozynska O, Kusche-Gullberg M, Lindahl U, Emerson CP Jr (2003) QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling. J Cell Biol 162:341–351PubMedCrossRef
41.
Zurück zum Zitat van den Born J, Salmivirta K, Henttinen T et al (2005) Novel heparan sulfate structures revealed by monoclonal antibodies. J Biol Chem 280:20516–20523PubMedCrossRef van den Born J, Salmivirta K, Henttinen T et al (2005) Novel heparan sulfate structures revealed by monoclonal antibodies. J Biol Chem 280:20516–20523PubMedCrossRef
Metadaten
Titel
Insulin modulates the secretion of proteins from mature 3T3-L1 adipocytes: a role for transcriptional regulation of processing
verfasst von
P. Wang
J. Keijer
A. Bunschoten
F. Bouwman
J. Renes
E. Mariman
Publikationsdatum
01.10.2006
Verlag
Springer-Verlag
Erschienen in
Diabetologia / Ausgabe 10/2006
Print ISSN: 0012-186X
Elektronische ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-006-0321-5

Weitere Artikel der Ausgabe 10/2006

Diabetologia 10/2006 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.